About Vanda

Board of Directors

Vincent J. Milano

Vincent J. Milano has served as Chief Executive Officer of Idera Pharmaceuticals, Inc. since December 2014. Prior to his tenure at Idera, Mr. Milano served as President and Chief Executive Officer of ViroPharma Incorporated from March 2008 until January 2014, the date which the company was acquired by Shire Pharmaceuticals. Mr. Milano served as Chief Operating Officer from January 2006 to March 2008, and as Vice President, Chief Financial Officer of ViroPharma from November 1997 to March 2008. Mr. Milano also previously served as Vice President, Finance & Administration, Treasurer, and as Executive Director, Finance & Administration of ViroPharma. Prior to joining ViroPharma, Mr. Milano was with KPMG LLP, independent certified public accountants, where he was a Senior Manager from 1991 to 1996.

Mr. Milano also serves on the boards of Idera Pharmaceuticals and Spark Therapeutics, both publicly traded companies, and VenatoRx, a privately held company.

Mr. Milano received his Bachelor of Science degree in Accounting from Rider College.

« return to board of directors

Home | About Vanda | Products | Pipeline | Partnering | Investor Relations | News | Careers | Contact Us
Copyright © 2019 Vanda Pharmaceuticals | Terms & Conditions | Privacy Policy